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The clinical relevance of attentional bias in
substance use disorders
Matt Field,1* Reshmi Marhe,2,3 and Ingmar H. A. Franken2
1 School of Psychology, University of Liverpool, Liverpool, UK
2 Institute of Psychology, Erasmus University Rotterdam, Rotterdam, The Netherlands
3 Department of Child and Adolescent Psychiatry, VU University Medical Centre, Amsterdam, The Netherlands
Individuals with substance use disorders typically show an ‘‘attentional bias’’ for substance-related cues: Those cues are
able to grab and hold the attention, in preference to other cues in the environment. We discuss the theoretical context for
this work before reviewing the measurement of attentional bias, and its relationship to motivational state and relapse to
substance use after a period of abstinence. Finally, we discuss the implications of this research for the treatment of
substance use disorders. We conclude that attentional bias is associated with subjective craving, and that moment-
by-moment fluctuations in attentional bias may precede relapse to substance use. The evidence regarding the predictive
relationship between attentional bias assessed in treatment contexts and subsequent relapse is inconsistent. Furthermore,
there is currently insufficient evidence to endorse attentional bias modification as a treatment for substance use
disorders. Clinical implications and suggestions for future research are highlighted.
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Clinical Implications
> Attentional bias should be discussed with substance
abusing patients as a component of psychosocial
interventions. They should be advised that it may
function as an ‘‘early warning signal’’ for imminent
relapse, so that they can act accordingly (for
example, distancing themselves from a high-risk
situation) if they become aware of it.
> Based on the ambiguous evidence to date, we do
not recommend assessing attentional bias in
treatment settings for clinical purposes (for example,
in order to identify those who are at risk of treatment
dropout or relapse).
> Based on the available evidence, we do not
recommend incorporating attentional bias
modification (ABM) into treatment programs,
until the intervention has been evaluated in a
large-scale clinical trial.
Introduction
Motivationally salient cues attract and hold selective
attention, and this ‘‘attentional bias’’ is related to indivi-
dual differences in appetitive and aversive motivation.
For example, anxious emotional states and anxiety
disorders are reliably characterized by an attentional
bias for threatening information.1 Attentional biases for
substance-related cues are seen in those with substance
use disorders, and the strength of attentional bias for
alcohol cues is proportional to individual differences in
alcohol consumption in nondependent alcohol con-
sumers.2 The purpose of this review is to explain the
theoretical context of attentional bias research related
to substance use disorder, describe some of the ways in
which it is measured, and provide a critical discussion
of the relevance of attentional bias in clinical settings.
Theoretical Background
Attentional bias for drug-related cues is thought to
develop as a consequence of a classical conditioning
process. Repeated pairings of drug-related cues (con-
ditioned stimuli) with the rewarding effects of those
drugs (unconditioned stimuli) results in the elicitation
of conditioned responses when exposed to those drug
cues. Conditioned responses may include attentional
orienting toward the cue, increased subjective craving,
physiological arousal, and drug-seeking behavior.
According to some theoretical models, the attentional
orienting response (attentional bias) may directly
modulate the other responses to drug-related cues.2,3
General models of addiction describe neuroadapta-
tions and psychological changes that underlie the shift
from recreational substance use to the loss of control
over use that is arguably the defining feature of
substance use disorders.4 For example, sensitization of
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dopamine function may occur in subcortical structures
that govern reward and associative learning, resulting
in strong cravings and an increase in the incentive-
motivational ‘‘pull’’ of substance-related cues, such as
the sight and smell of alcoholic drinks.5 In addition,
hypoactivity in distinct subregions of the prefrontal
cortex results in reduced inhibition of subcortical
structures, which manifests as executive dysfunction
and loss of control over behavior.6 Cognitive models of
addiction make predictions that can be overlaid on these
neurobiological models. For example, dual-process
models7 posit that repeated substance use leads to an
increase in automatic appetitive processing of substance
cues, including attentional biases and automatic
approach behavior directed toward those cues, com-
bined with suppression of cognitive control processes
that ordinarily mitigate the impact of automatic pro-
cesses on behavior. Finally, a hybrid neurobiological–
cognitive model3 proposes that ‘‘a drug stimulus produces
an increase in dopamine levels in the corticostriatal
circuit y which in turn serves to draw the subject’s
attention toward a perceived drug stimulus. This
process results in motor preparation and a hyper-
attentive state towards drug-related stimuli that,
ultimately, promotes further craving and relapse’’
(p. 563). A schematic overview of this model is shown
in Figure 1.
When we combine these theoretical models, the
following predictions emerge:
1. Attentional bias for substance-related cues is a
characteristic of substance use disorders.
2. The bias is associated with the strength of craving at
that moment in time.
3. Strong attentional bias increases the risk of relapse
to substance use in those who are attempting to
remain abstinent or to reduce their substance use.
These predictions will be evaluated in this article.
Measurement of Attentional Bias
Attentional bias for substance-related cues can be
measured directly (for example, by monitoring eye
movements), or it can be indirectly inferred with
reaction time or other measures. Indirect measures of
attentional bias, particularly the modified Stroop and
visual probe tasks, are the most commonly used tasks
in part because of their ease of administration. In the
word version of the addiction Stroop task, participants
are presented with words that are printed in different
colors and they are required to name the ink color in
which the words are printed while ignoring the
semantic content of the words. Substance abusers,
but not control subjects, are generally slower to name
the color of substance-related words (eg, ‘‘pipe,’’ ‘‘crack’’)
compared to matched neutral words (eg, ‘‘desk,’’
‘‘chair’’), which is interpreted as involuntary automatic
processing of the drug-related words.8 In a typical
visual probe task, a drug-related picture (eg, a pack of
cigarettes) is presented alongside a matched neutral
picture (eg, a pack of pens) on a computer screen for a
short period (typically between 50 and 2000 milli-
seconds). The pictures are then removed from the
display to be immediately replaced by a visual probe
that appears on either the left or right of the screen,
such that it appears either in the spatial location that
had been occupied by the drug-related picture or on
the opposite side of the screen. Participants are
instructed to respond to this probe as quickly as
possible: If they are consistently faster to respond to
probes that replace drug pictures compared to neutral
pictures, we assume that they were looking at the
drug-related picture (ie, attentional bias). Studies using
this task have generally revealed attentional bias for
drug cues among those with tobacco, opiate, or cocaine
dependence.2 The picture in alcohol abusers is more
complex: light drinkers show no bias, heavy drinkers
who are not seeking treatment generally show atten-
tional bias for alcohol cues, whereas alcohol-dependent
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Figure 1. Schematic illustrating the activation of attentional
bias and its possible relationship with craving, drug use,
and relapse. A drug-related cue is perceived and evokes an
increase in dopaminergic activity in subcortical structures,
causing it to be flagged as ‘‘salient,’’ and thereby grabbing
the attention. The individual then ruminates on drug use,
is unable to engage coping mechanisms, finds it difficult to
disengage from the cue, and experiences an increase in
craving. This causes further increases in craving, creating
a vicious cycle that may ultimately result in relapse.
Reproduced with permission from Franken (2003)(3).
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patients who are receiving treatment may show overt
attentional avoidance of alcohol cues.9
In recent years, both of these tasks have been criticized
owing to their poor internal reliability,10 and due to
ambiguity about the attentional subprocesses that they
measure.2 These criticisms may not apply to more direct
measurements of attentional bias, such as eye movement
monitoring.11 For example, direct measurement of
participants’ eye movements while they complete a
visual probe task reveals that substance abusers hold
their gaze on substance-related cues for longer than on
neutral cues, and this bias tends to be highly correlated
with the reaction time index of attentional bias that is
obtained from the task.12 Although direct measurement
of attentional biases using eye-tracking may be prefer-
able to indirect measures due to the superior reliability
and construct validity of eye-tracking, indirect measures
may be preferred for practical purposes, including the
high cost of eye-tracking equipment.
In addition to using reaction time tasks to measure
attentional bias, investigators have recently studied the
neural substrates of attentional bias using functional
magnetic resonance imaging (fMRI) and electroencepha-
lography (EEG) measures. Two specific electrophysiolo-
gical indices of cognitive processing, the P300 and slow
potential (SP) components of the event-related brain
potential (ERP), are associated with the deployment of
attentional resources to visual stimuli. A recent meta-
analysis13 showed that the P300 and SP amplitudes in
response to substance cues are typically larger in
substance abusers than controls. In addition, some recent
fMRI studies showed that activation in the anterior
cingulate cortex,14–18 dorsolateral prefrontal cortex,15,18,19
insula,14,16,18 nucleus accumbens,17 and amygdala16,18,20
is associated with attentional bias for substance-relevant
stimuli as compared to neutral stimuli. Therefore, these
specific EEG and fMRI indices of brain activation could
also be used as indirect measures of attentional bias.
Does Attentional Bias Predict Who Will Relapse?
In addition to the numerous studies that show cross-
sectional associations between attentional bias and
substance use, one study revealed that individual
differences in attentional bias for alcohol cues pre-
dicted future drinking behavior in a sample of heavy
drinkers who were not seeking treatment. In this
study, participants in whom attentional bias was low
at baseline showed larger reductions in drinking at
6-month follow-up compared to participants in whom
attentional bias was high at baseline.21 Based on this,
we might expect that attentional bias, assessed during
or shortly after treatment for substance dependence,
would be a useful predictor of the likelihood that
patients could maintain abstinence in the long-term.
Individuals with elevated attentional bias should be
less likely to maintain abstinence in the long-term.
Some studies appear to support this prediction:
Individual differences in drug Stroop interference
assessed in the clinic predict the likelihood of remain-
ing abstinent after discharge.16,22–26 However, several
studies that used either the visual probe task or the
modified Stroop (or both) failed to find this relationship
between behavioral measures of attentional bias assessed
in the clinic and subsequent relapse.27–29 The incon-
sistency may be partly attributable to variations in
methods (eg, attentional bias measure used, duration of
follow-up) and populations studied. For example, closer
inspection of individual studies suggests that attentional
bias may be a more robust predictor of relapse in the first
few days after treatment, but at longer follow-up periods
(typically, several months), this predictive relationship is
more inconsistent. Overall, the evidence that attentional
bias for drug cues assessed during treatment is a reliable
predictor of subsequent relapse is equivocal, and more
studies are needed before synthesizing this research in a
systematic review.
Some recent findings suggest a resolution to this
issue. For example, a recent study showed that anterior
cingulate cortex activation during performance of a
cocaine Stroop task predicted cocaine use at 3 month
follow-up, whereas behavioral performance on the
cocaine Stroop task did not.29 This suggests that
patterns of brain activity that are correlated with
attentional bias may be more sensitive predictors of
future drug use than behavioral measures of the bias.
In addition, two recent studies measured attentional
bias using experience sampling techniques, which
involved participants completing a drug Stroop task
on a handheld computer when prompted to do so at
random intervals throughout the day, or when they
experienced a temptation to use the drug. These
studies revealed that attentional bias was elevated in
the hours before participants reported being tempted
to use heroin and cocaine,30 and elevated attentional
bias preceded relapse.31 See Figure 2. We await
replication of these findings, but they suggest that
attentional bias for drug cues may peak in the days
before participants relapse, which would be consistent
with the theoretical model depicted in Figure 1.3 On
the other hand, when attentional bias is assessed in a
treatment setting using only behavioral measures, this
may not be a robust predictor of relapse to drug use
several months later. We address this topic in the
following section.
Attentional Bias Fluctuates with Motivational State
There is much debate about the conceptualization of
subjective drug craving, its measurement, and its
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clinical significance.3,5 As predicted by Franken3 (see
Figure 1), there is a small but robust association
between the magnitude of attentional bias and the
strength of subjective craving for the drug.32 Importantly,
the magnitude of the correlation between the two
increases when attention is measured directly (for
example, with eye movements) rather than being
indirectly inferred from reaction time measures (such
as the drug Stroop task). Therefore, attentional bias
seems to be associated with the strength of drug
craving, but the two are not synonymous. Given that
craving fluctuates within individuals over time,33 we
might expect attentional bias to do the same, and
indeed the aforementioned experience sampling stu-
dies suggest a large degree of within-subject variation
in the magnitude of attentional bias.30,31 Experimental
studies with heavy drinkers and tobacco smokers reveal
that attentional biases are increased as a consequence of
stress,34 alcohol intoxication,35,36 withdrawal (from
tobacco),37 exposure to drug cues,38,39 and having an
imminent opportunity to consume the substance.40,41
Each of these factors (eg, stress, alcohol intoxication,
opportunity) is known to increase the desire in the
laboratory to consume the drug. Furthermore, self-
report data from patients who relapsed indicate that
these factors can be a trigger for relapse after a period
of abstinence. Therefore, when considered alongside
recent experience sampling studies,30,31 attentional
bias may peak during ‘‘high-risk’’ situations for relapse
alongside increases in subjective craving. This may
also clarify why we see mixed findings regarding the
predictive validity of attentional bias when assessed in
treatment contexts. In these contexts, most of these
triggers are likely to be absent: Withdrawal symptoms
are likely to be well managed (by pharmacotherapy),
and there are no drug cues or opportunities to use the
drug within the treatment facility. Furthermore, when
patients are tested during or shortly after completing a
treatment program, they are likely to view their drug
use negatively, which may explain why alcoholic
inpatients show attentional avoidance of alcohol cues
in these circumstances.9 Considering these observa-
tions, we would not predict any robust predictive
relationship between attentional bias and relapse if
attentional bias is assessed in a treatment context, but
relapse occurs weeks or months later in very different
contexts. We await experience sampling studies in
naturalistic settings that can address these issues.
Treatment Implications
Attentional bias is a feature of substance use disorders,
it fluctuates in line with motivational state, and it may
peak in the days before people relapse to substance use
after a period of abstinence. It is important to consider
whether attentional bias could be a viable target for
novel treatment interventions. In order to answer
this question, we must first ask whether attentional
bias has a causal influence on the risk of relapse or
the strength of drug craving. A number of studies
investigated this issue by first experimentally manip-
ulating attentional bias for alcohol or tobacco cues in
the laboratory, and then exploring the effects of these
manipulations on subjective craving and drug-seeking
behaviors that were measured immediately after the
training. Despite some promising initial findings,42
a series of studies have failed to demonstrate robust
effects of attentional bias modification (ABM) on crav-
ing or drug-seeking assessed in the laboratory.43–46
However, these studies involved only a single session
of ABM that was administered to college students who
were not motivated to reduce their drinking or
smoking behavior, which leaves open the possibility
that ABM may be an effective treatment for substance
abusers who are motivated to reduce their substance
use, or abstain altogether. Two studies investigated
the efficacy of multiple sessions of ABM in alcohol
abusers. One study47 investigated a Stroop-based ABM
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Figure 2. Attentional bias for drug cues assessed with a
modified Stroop task administered on a handheld device
to participants while they were in their first week of
residential treatment. Participants completed the task at
randomly prompted intervals (RAs) or when tempted to use
the drug (TAs). Participants who relapsed versus those
who did not were distinguished. During TAs (but not RAs),
attentional bias was elevated in those who subsequently
relapsed versus those who did not. Furthermore, there
was a marked peak in attentional bias when assessed
soon before participants relapsed (proximal assessment)
compared to when assessed at other times (control
assessment). Overall, this study shows that attentional bias
is elevated in participants who relapse compared to
participants who do not, and bias is particularly high in the
days that precede a relapse. Reproduced with permission
from Marhe et al. (2013)(31).
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procedure and reported that heavy drinkers who
received it reported reductions in alcohol consumption
at follow-up. However, the absence of a control group
or any kind of mediation analysis in this study makes
it impossible to rule out nonspecific effects as an
explanation for the observed reduction in drinking.
Another study48 administered a visual probe–based
ABM procedure or a suitably matched control inter-
vention to alcohol-dependent patients who were
attempting to remain abstinent from alcohol. Groups
did not differ on overall relapse rates at follow-up,
although time-to-relapse was delayed in the group
receiving ABM compared to the control group.
However this was a small pilot study. A well-powered
clinical trial (using a similar methodology) is required
to obtain a more conclusive answer on the potential
clinical effectiveness of ABM as a treatment interven-
tion for substance use disorders. In this context, it is
notable that ABM for threat-related information has
shown some promise as an adjunct treatment for
anxiety disorders.49 One suggestion for future research
is to investigate the effectiveness of ABM if delivered
via handheld devices such as smartphones, so that
patients can benefit from a brief session of ABM if they
feel tempted to use the drug.30
Conclusions
Attentional bias for drug-related cues is a reliable
feature of substance use disorders. The bias fluctuates
in line with motivational state: It is correlated with the
strength of craving, and it increases in response to
manipulations such as stress, withdrawal, and cue
exposure, which are known to increase the risk of
relapse to drug use after a period of abstinence. If we
assess attentional bias in a treatment setting, it does
not seem to be a reliable predictor of relapse several
months later. However, moment-by-moment fluctua-
tions in attentional bias are meaningful, because
substance abusers are more likely to be tempted to
use drugs, and to relapse, when attentional bias is
high. At present, there is no convincing evidence to
recommend the use of attentional bias modification as
an adjunct treatment for substance use disorders,
although larger trials and alternative methodologies
are required to investigate this issue.
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